Alteration of nitric oxide synthase activity in young and aged apolipoprotein E-deficient mice

Neurobiology of Aging

Volumn 24, Issue 1, 2003, Pages 187-190

  Law, A ^a,b   Gauthier, S ^a,b,c   Quirion, R ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Beta amyloid; Cholinergic; Cognitive impairments; Cortex; Hippocampus; Inducible nitric oxide synthase; Microglia; Neuronal nitric oxide synthase; Neurotoxicity; Nitric oxide; Oxidative stress; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E; NITRIC OXIDE SYNTHASE;

AGED; AGING; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; WILD TYPE;

AGING; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; CEREBRAL CORTEX; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; RISK FACTORS;

EID: 0037213685     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00068-4     Document Type: Article

References (37)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5795-5800.
2. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
3. Dawson D.A. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovas. Brain Meta. Rev. 6:1994;299-324.
4. Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger in brain: the free radical, nitric oxide. Ann. Neurol. 32:1992;297-311.
5. Detmers P.A., Hernandez M., Mudgett J., Hassing H., Burton C., Mundt S.et al. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol. 165:2000;3430-3435.
6. Forster M.J., Dubey A., Dawson K.M., Stutts W.A., Lal H., Sohal R.S. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4765-4769.
7. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
8. Ii M., Sunamoto M., Ohnishi K., Ichimori Y. Beta-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res. 720:1996;93-100.
9. Kauser K., da C.V., Fitch R., Mallari C., Rubanyi G.M. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1679-H1685.
10. Krzywkowski P., Ghribi O., Gagne J., Chabot C., Kar S., Rochford J.et al. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice. Neuroscience. 92:1999;1273-1286.
11. Laskowitz D.T., Matthew W.D., Bennett E.R., Schmechel D., Herbstreith M.H., Goel S.et al. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport. 9:1998;615-618.
12. Law A., Dore S., Blackshaw S., Gauthier S., Quirion R. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience. 100:2000;769-775.
13. Law A., Gauthier S., Quirion R. Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br. J. Pharmacol. 133:2001;1114-1124.
14. Law A., O'Donnell J., Gauthier S., Quirion R. Neuronal and inducible nitric oxide synthase expressions and activities in the hippocampi and cortices of young adult, aged cognitively-unimpaired, and -impaired Long-Evans rats. Neuroscience. 112:2002;267-275.
15. Law A., Gauthier S., Quirion R. Say, NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Rev. 35:2001;73-96.
16. Lee S.C., Zhao M.L., Hirano A., Dickson D.W. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. J. Neuropathol. Exp. Neurol. 58:1999;1163-1169.
17. Mahley R.W., Nathan B.P., Pitas R.E. Apolipoprotein E - structure, function, and possible roles in Alzheimer's disease. Ann. N.Y. Acad. Sci. 777:1996;139-145.
18. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751:1997;307-314.
19. McGeer P.L., Walker D.G., Pitas R.E., Mahley R.W., McGeer E.G. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro. Brain Res. 749:1997;135-138.
20. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M.et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
21. Nims R.W., Cook J.C., Krishna M.C., Christodoulou D., Poore C.M., Miles A.M.et al. Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol. 268:1996;93-105.
22. Ohm TG, Hamker U, Cedazo-Minguez A, Rockl W, Scharnagl H, Marz W, et al. Apolipoprotein E and beta A4-amyloid: signals and effects. Biochem Soc Symp 2001;121-9.
23. Oitzl M.S., Mulder M., Lucassen P.J., Havekes L.M., Grootendorst J., de Kloet E.R. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752:1997;189-196.
24. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
25. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S.et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med. 27:1999;544-553.
26. Ramassamy C., Averill D., Beffert U., Theroux L., Lussier-Cacan S., Cohn J.S.et al. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol. Dis. 7:2000;23-37.
27. Ramassamy C., Krzywkowski P., Averill D., Lussier-Cacan S., Theroux L., Christen Y.et al. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Mol. Brain Res. 86:2001;76-83.
28. Riddell D.R., Vinogradov D.V., Stannard A.K., Chadwick N., Owen J.S. Identification and characterization of LRP8 (apoER2) in human blood platelets. J. Lipid Res. 40:1999;1925-1930.
29. Roses A.D., Pericak-Vance M.A., Yamaoka L., Haynes C., Speer M., Gaskell P.et al. Linkage studies in familial Alzheimer's disease. Prog. Clin. Biol. Res. 317:1989;201-215.
30. Sloane J.A., Hollander W., Moss M.B., Rosene D.L., Abraham C.R. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol. Aging. 20:1999;395-405.
31. Thorns V., Hansen L., Masliah E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp. Neurol. 150:1998;14-20.
32. Veinbergs I., Mallory M., Mante M., Rockenstein E., Gilbert J.R., Masliah E. Differential neurotrophic effects of apolipoprotein E in aged transgenic mice. Neurosci. Lett. 265:1999;218-222.
33. Vernet D., Bonavera J.J., Swerdloff R.S., Gonzalez-Cadavid N.F., Wang C. Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats. Endocrinology. 139:1998;3254-3261.
34. Vitek M.P., Snell J., Dawson H., Colton C.A. Modulation of nitric oxide production in human macrophages by apolipoprotein E and amyloid beta-peptide. Biochem. Biophys. Res. Commun. 240:1997;391-394.
35. Xu P.T., Schmechel D., Rothrock-Christian T., Burkhart D.S., Qiu H.L., Popko B.et al. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3:1996;229-245.
36. Yang S.N., Hsieh W.Y., Liu D.D., Tsai L.M., Tung C.S., Wu J.N. The involvement of nitric oxide in synergistic neuronal damage induced by beta-amyloid peptide and glutamate in primary rat cortical neurons. Chin. J. Physiol. 41:1998;175-179.
37. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Ann. Rev. Pharmacol. Toxicol. 35:1995;213-233.